Search
-
Unlock Strategic Advantage with Ipsos' New Insights Agent
Ipsos launches Insights Agent, its agentic AI solution to unlock faster, smarter decision-making by connecting your information and transforming it into impact.
-
Ipsos launches GLP-1 PersonaBot, designed to support companies’ understanding of the consumer obesity treatment market
Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.
-
Ipsos Answers Esomar’s Questions to help online research buyers
The primary aim of the ESOMAR's Questions is to increase transparency and raise awareness of the key issues for researchers to consider when deciding whether an online sampling approach is fit for their purpose.
-
Ipsos Launches AI-Powered Risk Informer for Real-Time, Project-Based Risk Monitoring
Discover How Our AI-Powered Platform Transforms Risk Management and Sustainability Compliance
-
Ipsos at the 2024 ESOMAR conference
Uncover the insights shared by our experts during the ESOMAR 2024 event.
-
Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.